First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT03666988 · TERMINATED
Trial details
- NCT number
- NCT03666988
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2021-03-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.